These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1183 related articles for article (PubMed ID: 30972078)

  • 21. DNA vaccines: a mini review.
    Saha R; Killian S; Donofrio RS
    Recent Pat DNA Gene Seq; 2011 Aug; 5(2):92-6. PubMed ID: 21574950
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [mRNA vaccines for infectious diseases: research progress and applications].
    Qin F; Ren N; Cheng W; Wei H
    Sheng Wu Gong Cheng Xue Bao; 2023 Oct; 39(10):3966-3984. PubMed ID: 37877385
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DNA vaccines: an historical perspective and view to the future.
    Liu MA
    Immunol Rev; 2011 Jan; 239(1):62-84. PubMed ID: 21198665
    [TBL] [Abstract][Full Text] [Related]  

  • 24. mRNA vaccination as a safe approach for specific protection from type I allergy.
    Weiss R; Scheiblhofer S; Roesler E; Weinberger E; Thalhamer J
    Expert Rev Vaccines; 2012 Jan; 11(1):55-67. PubMed ID: 22149709
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Current Landscape of mRNA Vaccines Against Viruses and Cancer-A Mini Review.
    Ladak RJ; He AJ; Huang YH; Ding Y
    Front Immunol; 2022; 13():885371. PubMed ID: 35603213
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Self-assembled mRNA vaccines.
    Kim J; Eygeris Y; Gupta M; Sahay G
    Adv Drug Deliv Rev; 2021 Mar; 170():83-112. PubMed ID: 33400957
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Automated mass immunization of poultry: the prospect for nonreplicating human adenovirus-vectored in ovo vaccines.
    Avakian AP; Poston RM; Kong FK; Van Kampen KR; Tang DC
    Expert Rev Vaccines; 2007 Jun; 6(3):457-65. PubMed ID: 17542759
    [TBL] [Abstract][Full Text] [Related]  

  • 28. From plasmids to protection: a review of DNA vaccines against infectious diseases.
    Laddy DJ; Weiner DB
    Int Rev Immunol; 2006; 25(3-4):99-123. PubMed ID: 16818367
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Messenger RNA-Based Vaccines Against Infectious Diseases.
    Alameh MG; Weissman D; Pardi N
    Curr Top Microbiol Immunol; 2022; 440():111-145. PubMed ID: 32300916
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthetic vaccines for infectious and autoimmune diseases.
    Sela M
    Adv Exp Med Biol; 1996; 397():1-5. PubMed ID: 8718575
    [No Abstract]   [Full Text] [Related]  

  • 31. mRNA vaccines - a new era in vaccinology.
    Pardi N; Hogan MJ; Porter FW; Weissman D
    Nat Rev Drug Discov; 2018 Apr; 17(4):261-279. PubMed ID: 29326426
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Subunit vaccines--antigens, carriers, conjugation methods and the role of adjuvants].
    Jarząb A; Skowicki M; Witkowska D
    Postepy Hig Med Dosw (Online); 2013 Nov; 67():1128-43. PubMed ID: 24379254
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recent advances in the administration of vaccines for infectious diseases: microneedles as painless delivery devices for mass vaccination.
    Hegde NR; Kaveri SV; Bayry J
    Drug Discov Today; 2011 Dec; 16(23-24):1061-8. PubMed ID: 21782969
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Formulation and Delivery Technologies for mRNA Vaccines.
    Zeng C; Zhang C; Walker PG; Dong Y
    Curr Top Microbiol Immunol; 2022; 440():71-110. PubMed ID: 32483657
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Parainfluenza virus 5-vectored vaccines against human and animal infectious diseases.
    Chen Z
    Rev Med Virol; 2018 Mar; 28(2):. PubMed ID: 29316047
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Engineering DNA vaccines against infectious diseases.
    Lee J; Arun Kumar S; Jhan YY; Bishop CJ
    Acta Biomater; 2018 Oct; 80():31-47. PubMed ID: 30172933
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent Advances in the Use of Plant Virus-Like Particles as Vaccines.
    Balke I; Zeltins A
    Viruses; 2020 Feb; 12(3):. PubMed ID: 32121192
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High throughput genomic and proteomic technologies in the fight against infectious diseases.
    Tanca A; Deligios M; Addis MF; Uzzau S
    J Infect Dev Ctries; 2013 Mar; 7(3):182-90. PubMed ID: 23492995
    [TBL] [Abstract][Full Text] [Related]  

  • 39. From vaccine practice to vaccine science: the contribution of human immunology to the prevention of infectious disease.
    Mortellaro A; Ricciardi-Castagnoli P
    Immunol Cell Biol; 2011 Mar; 89(3):332-9. PubMed ID: 21301476
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Advances in nanoparticle-based mRNA delivery for liver cancer and liver-associated infectious diseases.
    Chung S; Lee CM; Zhang M
    Nanoscale Horiz; 2022 Dec; 8(1):10-28. PubMed ID: 36260016
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 60.